K260244

Substantially Equivalent

Auryon Atherectomy System

The Auryon Atherectomy System is a laser-based peripheral atherectomy device for removing plaque from peripheral arteries — primarily in the legs and below the knee. Product code MCW covers catheter-based atherectomy devices. Auryon is AngioDynamics' platform (originally from Eximo Medical, which AngioDynamics acquired); continuing filings from Eximo Medical suggest ongoing regulatory maintenance post-acquisition.

Cardiovascular panel, Traditional 510(k). Laser atherectomy sits in a specialized niche within MCW alongside directional (Philips), orbital (Abbott), and rotational (Boston Scientific) platforms.

Eximo Medical files from Rehovot, Israel, where the original development occurred. Roughly two-and-a-half-month review clock, unusually short for Cardiovascular panel on a device with this complexity.

Applicant
Eximo Medical
Product code
MCW
Advisory panel
Cardiovascular
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Rehovot, IL
Download summary PDF View on FDA.gov ↗

Adverse events under product code MCW

product code MCW
Death
38
Injury
1,386
Malfunction
2,676
Other
2
Total
4,102

Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.